TBZ2862
Everolimus;42-O-(2-Hydroxyethyl)-rapamycin;Certica;RAD-001;SDZRAD;Rapamycin, 42-O-(2-hydroxyethyl)-;Certican;CERTICAN(R);Everolimus (RAD001);Everolimus (RAD001, SDZ-RAD, Afinitor®, Certican®, and Zortress®);Everolimus solution; Afinitor;RAD001;SDZ-RAD;Zortress;EVEROLIMUS(WITHOUT BHT);40-O-(2-Hydroxyethyl)rapamycin;42-O-(2-Hydroxyethyl)rapamycin;CERTICAN®;23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine,rapamycin deriv.;42-O-(2-Hydroxy)ethylrapamycin;RAD;XIENCE V;EveroliMus API;Everolimus(RAD001);Votubia;40-O-(2-hydroxyethyl)-rapamycin;Afinitor Disperz;RAD 001;9HW64Q8G6G;Everolimus, >=98%
C53H83NO14
958.22
